Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Desitin Pharma AS
AS
Active
Org 976592492
Meierisvingen 2, 1383
Asker
Activities of advertising agencies
·
NACE 7311
Est. 1996 · 30 years old
5 employees
Monitor
Share
Norway
/
Companies
/
Activities of advertising agencies
/
Desitin Pharma AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
15M
11M
7M
4M
0M
2021: 11M
11M
2021
2022: 12M (+9% vs 2021)
12M
+9%
2022
2023: 12M (0% vs 2022)
12M
0%
2023
2024: 9M (-25% vs 2023)
9M
-25%
2024
2025: 10M (+11% vs 2024)
10M
+11%
2025
EBITDA
NOK millions
2M
2M
1M
1M
0M
2021: 1M
1M
2021
2022: 2M (+100% vs 2021)
2M
+100%
2022
2023: 1M (-50% vs 2022)
1M
-50%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
9 532
8 894
11 993
12 420
10 571
Staff expenses
−4 748
−4 809
−5 544
−6 188
−0
EBITDA
1 073
1 280
1 461
1 568
1 374
Depreciation & amort.
−106
−131
−255
−308
−361
EBIT
967
1 149
1 206
1 260
1 013
Net financials
70
63
4
−10
3
Profit before tax
1 038
1 213
1 211
1 250
1 016
Tax
244
228
−1 490
324
235
Net profit
793
984
2 701
925
781
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
22 648
22 487
22 559
20 159
21 314
Equity
20 605
19 811
18 827
16 126
16 101
Long-term debt
0
0
0
0
0
Short-term debt
2 043
2 675
3 731
4 032
5 213
Total debt
2 043
2 675
3 731
4 032
5 213
Financial ratios
5-year trend
EBITDA margin
11,3 %
This company
15,8 %
Market median
This company
Market median
28% below market
2021
2025
Equity ratio
91,0 %
This company
38,2 %
Market median
This company
Market median
138% above market
2021
2025
Return on equity
3,8 %
This company
18,4 %
Market median
This company
Market median
79% below market
2021
2025
Net profit margin
8,3 %
This company
8,1 %
Market median
This company
Market median
2% above market
2021
2025
Asset turnover
0,42×
This company
1,12×
Market median
This company
Market median
63% below market
2021
2025
Debt / equity
0,10×
This company
0,62×
Market median
This company
Market median
84% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-10-01 – 2021-09-30
View
PDF
More on Desitin Pharma AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
